Support Statement

This activity is supported by an educational grant from Gilead Sciences.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.

Disclosure and Conflict of Interest Policy

It is the policy of HealthHIV to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All individuals planning or participating in educational activities sponsored or co-sponsored by HealthHIV must disclose relationships with commercial entities that may have a financial interest in the educational activity. HealthHIV will review these relationships and take action to resolve any conflicts of interest prior to the activity.

Disclosures are collected and resolved at the time of planning. Disclosures represent the financial relationships individuals have with ineligible companies at the time of disclosure. A company is considered ineligible when its primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. These include pharmaceutical, medical devices, and other companies that produce healthcare products.

Faculty Disclosures

HealthHIV requires all individuals in a position to control educational content to disclose all financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Omar Martinez, JD, MPH, MS

Disclosure: Omar Martinez  has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Joseph Cherabie, MD, MSc

Joseph Cherabie has disclosed the following relevant financial relationship with an ineligible company:

– Advisor, Consultant, or Independent Contractor for Gilead and Innoviva Pharmaceuticals

This relationship has been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HealthHIV and the planners of this educational activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of HealthHIV. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

TThere are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at [email protected].

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (80% is required for ABS).

For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.

About This Activity

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.

The materials presented here are used with the permission of the authors and/or other sources.

If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at [email protected]. A member of our team will be happy to assist you.

If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at [email protected].